Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic.

Monroy-Iglesias, Maria Jose; Hadi, Hajer; Russell, Beth; Moss, Charlotte; Flanders, Lucy; Dolly, Saoirse; Papa, Sophie; Van Hemelrijck, Mieke

Monroy-Iglesias, Maria Jose; Hadi, Hajer; Russell, Beth; Moss, Charlotte; Flanders, Lucy; Dolly, Saoirse; Papa, Sophie; Van Hemelrijck, Mieke.

Monroy-Iglesias MJ; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK.
Hadi H; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK.
Russell B; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK.
Moss C; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK.
Flanders L; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.
Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.
Papa S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.
Van Hemelrijck M; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK.

J Eur Acad Dermatol Venereol ; 2022 Aug 16.

Article in English | MEDLINE | ID: covidwho-2243442

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18514

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google